CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for SensiVida Medical Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

SensiVida Medical Technologies Inc
150 Lucius Gordon Dr Ste 110
Phone: (215) 485-0362p:215 485-0362 WEST HENRIETTA, NY  14586-9687  United States Fax: (585) 272-0229f:585 272-0229

On 4/16/2015, the U.S. Securities and Exchange Commission revoked the registration of each class of registered securities of SensiVida Medical Technologies Inc for failure to make required periodic filings with the Commission.
This company is no longer actively traded on any major stock exchange.

Business Summary
SensiVida Medical Technologies, Inc. is an invasive Diagnostic Device company. The Company’s Microsystems-based optical technology automates bio-sensing and data acquisition. The Company’s platform technology can be applied to a number of disease state diagnostics, such as Allergy Testing, pain-free automated Glucose Monitoring without bio-fouling, Blood Coagulation Testing, TB Testing and Cholesterol Monitoring. The Company has two products, including Allergy Test System and Glucose monitor system. The Company’s Allergy Test system offers the allergist, painless allergy testing system that consists of a disposable microlancet chip or cartridge that painlessly administers the allergens. The Glucose Monitoring System is an unobtrusive, wearable device with a disposable microlancet chip having individually-monitored sensors.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
5/31/20112/28/2011YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Interim Chief Executive Officer J. MontiethEstes 11/3/2011 10/10/2011
President, Director Jose M.Mir 59 8/27/2010 11/30/2008
Chief Financial Officer Frank D.Benick 62 11/15/2005 11/15/2005
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Laser Diagnostics Instruments, Inc.
Medi-Photonics Development L.L.C.
Mediscience Technology Corp.
5 additional Business Names available in full report.

General Information
Number of Employees: 3 (As of 5/31/2011)
Outstanding Shares: 16,088,112 (As of 5/31/2011)
Shareholders: 151
Stock Exchange: OTC
Federal Tax Id: 221937826
Fax Number: (585) 272-0229


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023